Sasha
Senior Member (Voting Rights)
You can't ethically expose people to Covid so they just had to give people the real or placebo vaccine and let them live their lives.Do we know how many of them were exposed to covid though?
You can't ethically expose people to Covid so they just had to give people the real or placebo vaccine and let them live their lives.Do we know how many of them were exposed to covid though?
Yeah I read more and apparently it's because, out of the 94 people who developed covid, 90% of them had received the placebo instead of the vaccine. I don't understand how that means that the vaccine is "90% effective".
I guess we also don't know how many of the 43000 people were exposed to covid?
My sentiments entirely Mij, I'm not anti-vax by any stretch of the imagination, but anyone who just takes their word for it is a bit naive iyam. It will need to be seriously scrutinised. I hope that need for scrutiny & interrogation of the rsearch will not be lost in the relief and urgent longing for a vaccine to 'save us' & save our way of life.
Why the figure of 90% effective, when only 94 out of 43000 people developed covid?
I found this blog useful in explaining
https://phastar.com/blog/250-statisticians-view-on-pfizer-covid19-vaccine-data
If I understand correctly the 43000 is the number of people enroled in the trial and they sample when 90 people get covid and then look at effectiveness. So 8 in the vaccine group will have got covid compared to 86 in the control group.
They would randomise them to either the placebo or active vaccine arm and the randomisation ought to have delivered equalish exposure to the virus.But how do they know if the two groups of people had the same exposure to the virus? Are their assumptions on this valid?
But how do they know if the two groups of people had the same exposure to the virus? Are their assumptions on this valid?
They don't know. They just hope their randomisation wasn't biased in any way.
The daily pill, first earmarked as a potential Covid game-changer by a British firm, reduces deaths by 71 per cent in those with moderate or severe illness, researchers say.
Importantly, it works in the elderly, raising hopes that it will save the most vulnerable.
Called baricitinib, and marketed under the brand name Olumiant, it is a relatively new drug for rheumatoid arthritis that has been available for only three years.
Arthritis drug 'cuts elderly Covid-19 deaths by two-thirds'
http://www.msn.com/en-gb/health/med...-deaths-by-two-thirds/ar-BB1b179f?ocid=ASUDHP
So that's now allegedly two vaccines we have which sound as though they might be viable - and the new one doesn't need to be deep-frozen, which is good. But I still don't understand how researchers can be so sure they're so effective if they don't know how many of their test subjects have actually been exposed to the virus ...
They judge exposure by how many of the placebo people got the virus.So that's now allegedly two vaccines we have which sound as though they might be viable - and the new one doesn't need to be deep-frozen, which is good. But I still don't understand how researchers can be so sure they're so effective if they don't know how many of their test subjects have actually been exposed to the virus ...
So that's now allegedly two vaccines we have which sound as though they might be viable - and the new one doesn't need to be deep-frozen, which is good. But I still don't understand how researchers can be so sure they're so effective if they don't know how many of their test subjects have actually been exposed to the virus ...